AU2985499A - Non-peptide bradykinin receptor antagonists for use in treating ophthalmic diseases and disorders - Google Patents
Non-peptide bradykinin receptor antagonists for use in treating ophthalmic diseases and disordersInfo
- Publication number
- AU2985499A AU2985499A AU29854/99A AU2985499A AU2985499A AU 2985499 A AU2985499 A AU 2985499A AU 29854/99 A AU29854/99 A AU 29854/99A AU 2985499 A AU2985499 A AU 2985499A AU 2985499 A AU2985499 A AU 2985499A
- Authority
- AU
- Australia
- Prior art keywords
- disorders
- receptor antagonists
- ophthalmic diseases
- bradykinin receptor
- treating ophthalmic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8000398P | 1998-04-03 | 1998-04-03 | |
US60080003 | 1998-04-03 | ||
PCT/US1999/004866 WO1999051245A1 (en) | 1998-04-03 | 1999-03-04 | Non-peptide bradykinin receptor antagonists for use in treating ophthalmic diseases and disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2985499A true AU2985499A (en) | 1999-10-25 |
Family
ID=22154279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU29854/99A Abandoned AU2985499A (en) | 1998-04-03 | 1999-03-04 | Non-peptide bradykinin receptor antagonists for use in treating ophthalmic diseases and disorders |
Country Status (4)
Country | Link |
---|---|
US (1) | US6531480B1 (en) |
AR (1) | AR018825A1 (en) |
AU (1) | AU2985499A (en) |
WO (1) | WO1999051245A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU680870B2 (en) | 1993-04-28 | 1997-08-14 | Astellas Pharma Inc. | New heterocyclic compounds |
US20070225225A1 (en) * | 2006-02-28 | 2007-09-27 | Sharif Najam A | Use of natriuretic peptide receptor antagonists to treat ocular, otic and nasal edemetous conditions |
US20080160366A1 (en) * | 2006-12-29 | 2008-07-03 | Allen Glenn M | Porous plate for a fuel cell |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2646773B1 (en) | 1989-05-12 | 1994-05-13 | Chauvin Sa Laboratoire | PHARMACEUTICAL COMPOSITION BASED ON PARACETAMOL |
EP0529499A1 (en) * | 1991-08-22 | 1993-03-03 | Hoechst Aktiengesellschaft | Compositions for topical administration to the nose or the eyes containing bradykinin antagonists |
JPH10316677A (en) * | 1997-05-19 | 1998-12-02 | Fujisawa Pharmaceut Co Ltd | Crystal |
-
1999
- 1999-03-04 US US09/647,640 patent/US6531480B1/en not_active Expired - Fee Related
- 1999-03-04 AU AU29854/99A patent/AU2985499A/en not_active Abandoned
- 1999-03-04 WO PCT/US1999/004866 patent/WO1999051245A1/en active Application Filing
- 1999-03-31 AR ARP990101487A patent/AR018825A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1999051245A1 (en) | 1999-10-14 |
US6531480B1 (en) | 2003-03-11 |
AR018825A1 (en) | 2001-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1046274A1 (en) | Spiro Ä1-azabicycloÄ2.2.2.Üoctane-3,2'(3'h)-furoÄ2,3-bÜpyridine for use in the treatment of psychotic and intellectual impairment disorders. | |
EP1233728A4 (en) | Ophthalmic device and method of manufacture and use | |
AU6894600A (en) | Therapeutic polypeptides and methods for using same | |
AU4713499A (en) | Ophthalmic uses of ppargamma agonists and ppargamma antagonists | |
AU2072201A (en) | Agents and methods for the treatment of proliferative diseases | |
AU4325499A (en) | Receptor ligand antagonist complexes and their use in treating or preventing receptor mediated diseases | |
AU2002317105A1 (en) | Methods for identifying therapeutic agents for treating diseases involving wnt polypeptides and wnt receptors | |
ZA964762B (en) | Peptidyl heterocycles useful in the treatment of thrombin related disorders. | |
EP1213018A4 (en) | Preventive and therapeutic agents for eye diseases | |
ZA964761B (en) | Peptidyl heterocycles useful in the treatment of thrombin related disorders. | |
IL120477A0 (en) | Fluoroalkyl - and fluoroalkoxy-substituted heterocyclic bradykinin antagonists process for their preparation and their use | |
AU5774699A (en) | Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders | |
IL162475A0 (en) | Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists | |
GB9712761D0 (en) | Quinolines and their therapeutic use | |
AU2985499A (en) | Non-peptide bradykinin receptor antagonists for use in treating ophthalmic diseases and disorders | |
AU4768899A (en) | Peptide antagonists of the human urokinase receptor and method for selecting them | |
AU6281298A (en) | Use of lofexidine in the treatment of behavioral disorders | |
AU2985399A (en) | Non-peptide bradykinin receptor antagonists for use in controlling intraocular pressure and treating glaucoma | |
AU2529799A (en) | Benzofuran-4-carboxamides and their therapeutic use | |
AU3116697A (en) | Human interleukin-1j and antagonists thereof | |
GB9826276D0 (en) | Therapeutic agents for use in degenerative disorders | |
AU1146401A (en) | Use of 5ht-1a-serotonine receptor agonists for treating genetic or functional rhythm disorders in the respiratory system | |
AU8667898A (en) | Use of alpha1a-adrenergic receptor antagonists in glaucoma therapy | |
EP0878200A4 (en) | Therapeutic agent for ophthalmic diseases | |
AU4537199A (en) | Device for laser therapy in ophthalmology and variants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |